The 20 Best Spinal Muscular Atrophy Type 2 Doctors Near Me in New York, NY

Douglas Sproule is a Neuromusculoskeletal Medicine provider practicing medicine in New York, New York. Dr. Sproule is rated as an Elite provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy Type 1, Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, and Spinal Muscular Atrophy Type 2.

Daniel Macgowan is a Neurologist practicing medicine in New York, New York. Dr. Macgowan is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.

Russell Chin is a Neuroradiologist practicing medicine in New York, New York. Dr. Chin is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Infantile Axonal Neuropathy, Congenital Insensitivity to Pain with Anhidrosis, and Hereditary Sensory and Autonomic Neuropathy Type 2.

Mary Chu is a Neuromusculoskeletal Medicine provider practicing medicine in New York, New York. Dr. Chu is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy with Arthrogryposis, X-Linked Infantile Spinal Muscular Atrophy, and Limb-Girdle Muscular Dystrophy.

Jeffrey Cohen is a Physiatrist practicing medicine in New York, New York. Dr. Cohen is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Poliomyelitis, Foot Drop, Relapsing Multiple Sclerosis (RMS), and Glycogen Storage Disease Type 0.

Stephen Scelsa is a Neurologist practicing medicine in New York, New York. Dr. Scelsa is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 3, and Spinal and Bulbar Muscular Atrophy.

Swati Sathe is a Neurologist practicing medicine in New York, New York. Dr. Sathe is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Huntington Disease, Movement Disorders, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, and Dementia.

Adina Wise is a Neurologist practicing medicine in New York, New York. Dr. Wise is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Parkinson's Disease, Movement Disorders, Primary Lateral Sclerosis, and Pyridoxine Deficiency.

Yaacov Anziska is a Neurologist practicing medicine in Brooklyn, New York. Dr. Anziska is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Neuromyelitis Optica, Necrotizing Myopathy (NM), and HTLV-1 Associated Myelopathy.

Dr. Constantinescu has an active clinical practice at Columbia University Medical Center, including care of children with asthma, cystic fibrosis, and technology-dependent conditions (home ventilation by invasive and non-invasive means, mechanically assisted airway clearance, etc.) He participates in the Muscular Dystrophy Clinic at Columbia, for the management of pulmonary complications of neuromuscular disorders. Through the multidisciplinary Motor Neuron Center at Columbia, Dr. Constantinescu is also involved in clinical research in the area of pulmonary function in neuromuscular disease. Dr. Constantinescu is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy Type 2, Duchenne Muscular Dystrophy, Cystic Fibrosis, and Congenital Central Hypoventilation Syndrome. Dr. Constantinescu is board certified in Pediatrics and Pediatric Pulmonology. Dr. Constantinescu is currently accepting new patients.

Dr. Chiriboga is Professor of Neurology and Pediatrics at CUIMC and former Interim Director of the Division of Child Neurology, Departments of Neurology and Pediatrics, Vagelos College of Physicians and Surgeons. She is also former Chief of Pediatric Neurology at Columbia University's affiliate hospital, Harlem Hospital Center.Dr. Chiriboga was born in Peru and educated in Argentina, where she graduated with Honors from the Faculty of Medicine at the National University of Buenos Aires in 1982. Dr. Chiriboga completed training in pediatrics at St. Luke's-Roosevelt Hospital in 1985. After completing her training in child neurology in 1988 at the Neurological Institute and Babies Hospital of Columbia-Presbyterian Medical Center, Dr. Chiriboga joined the Division of Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center. Subsequently, she completed a Neuroepidemiology fellowship at the Gertrude H. Sergievsky Center and received a Master in Public Health from the Mailman School of Public Health, Columbia University. Dr. Chiriboga serves/has served on committees of the NIH, CNS, and ABPN. She is a diplomate of the ABPN in Child Neurology.Dr. Chiriboga's current research focuses on Spinal Muscular Atrophy (SMA) clinical trials. Past areas of research, including NIH funding, has focused on congenital infections and neurodevelopmental disorders, including cerebral palsy and effects of perinatal exposures. Her clinical practice focuses on neuromuscular disorders as well as developmental, neurobehavioral neurology, and migraine, and on the treatment of spasticity. Dr. Chiriboga is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Spinal Muscular Atrophy Type 3. Dr. Chiriboga is board certified in Neurology With Special Qualification In Child Neurology and Child Neurology. Dr. Chiriboga is currently accepting new patients.

Zina Kroner is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Kroner is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses X-Linked Infantile Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy with Arthrogryposis, and Vitamin B12 Deficiency.

Petra Kaufmann is a Neurologist practicing medicine in New York, New York. Dr. Kaufmann is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy (SMA), and MELAS Syndrome.

Jennifer Bain, MD, PhD, is an Associate Professor of Neurology and Pediatrics at the Columbia University Medical Center. Dr. Bain completed both an MD and PhD, as well as general pediatrics residency at Rutgers – New Jersey Medical School in New Jersey. She then trained in Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center in New York City and is a board-certified neurologist with special certification in Child Neurology seeing both inpatient and outpatient pediatric neurology patients. Her clinic focuses on diagnosis and management of autism, cerebral palsy and neurodevelopmental disorders in addition to genetic disorders associated with such conditions.Her early research career focused on spinal cord and brain development after injuries such as spinal cord injury and perinatal hypoxic ischemic encephalopathy. During her residency training, her clinical research focused on studying autonomic dysfunction in children with autism spectrum disorders and neurological complications during extracorporeal membrane oxygenation. She currently works as a physician scientist at Columbia University specializing in general pediatric neurology with expertise in development, behavioral neurology, autism and cerebral palsy. Her clinical research has focused on studying the genetics of neurodevelopmental disorders including autism and cerebral palsy. The genes she has worked closely on include HNRNPH2 and related disorders, GRIN disorders, KIF1A. She is interested in understanding clinically meaningful measures in families affected by neurodevelopmental disorders and measuring longitudinal trajectories in such disorders. She has been working closely with several patient advocacy groups, researchers, and Simons Searchlight to continuously move forward in the understanding of the developing and aging brain. Dr. Bain is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses HNRNPH2-Related Disorder, Autism Spectrum Disorder, Early Infantile Epileptic Encephalopathy, and Cerebral Palsy. Dr. Bain is board certified in Neurology With Special Qualification In Child Neurology. Dr. Bain is currently accepting new patients.

Hana Azizi, MD, is an assistant professor in rehabilitation medicine at Columbia University Medical Center's Department of Rehabilitation and Regenerative Medicine.Dr. Hana Azizi graduated from Shiraz University of Medical Sciences and completed her residency in Physical Medicine and Rehabilitation at Montefiore Medical Center.She then pursued a fellowship training in Pediatric Rehabilitation at Rusk Rehabilitation Institute/New York University Langone Health. She works with children and their families using an interdisciplinary approach to address the prevention, diagnosis, treatment, and management of congenital and childhood-onset physical impairments.Physical Medicine and Pediatric Rehabilitation Medicine.Pediatric Rehabilitation Medicine Fellowship, NYU Langone Rusk Rehab. Dr. Azizi is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Moebius Syndrome, Spastic Diplegia Infantile Type, and Spasticity. Dr. Azizi is board certified in Physical Medicine And Rehabilitation. Dr. Azizi is currently accepting new patients.

Matthew Harms, MD is an Associate Professor of Neurology. Dr. Harms received his A.B. in Biology summa cum laude from Harvard University in 1997, and his medical doctorate from the University of California San Francisco in 2003. He remained at San Francisco for neurology residency and served as Chief Resident in his final year. Dr. Harms completed neuromuscular medicine and clinical neurophysiology fellowships under the mentorship of Dr. Alan Pestronk at Washington University in St. Louis. His clinical training in neuromuscular diseases led him into the laboratory of Dr. Robert Baloh, where his post-doctoral research identified the genes responsible for two orphan human diseases- dominant spinal muscular atrophy with lower extremity predominance and limb-girdle muscular dystrophy type 1D.Dr. Harms joined the neuromuscular medicine faculty at Washington University in 2009 with board certifications in neurology, clinical neurophysiology, and neuromuscular medicine. In 2011, Dr. Harms assumed leadership of the Washington University Neuromuscular Genetics Project and established his research laboratory to continue harnessing emerging genetic technologies to understand the causes of inherited neuromuscular diseases. The lab focuses on diseases of the motor neuron, including amyotrophic lateral sclerosis, spinal muscular atrophy, and the hereditary motor neuropathies, and where his efforts have helped identify more than 5 novel disease genes. Here at Columbia, he will continue these efforts, directing an international multi-site effort using whole genome and transcriptome sequencing to bring precision medicine to amyotrophic lateral sclerosis. His laboratory efforts will occur in both the Motor Neuron Center and the Institute for Genomic Medicine. Dr. Harms is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3. Dr. Harms is board certified in Neuromuscular Medicine, Neurology, and Clinical Neurophysiology. Dr. Harms is currently accepting new patients.

Michio Hirano is a Neurologist practicing medicine in New York, New York. Dr. Hirano is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Mitochondrial Neurogastrointestinal Encephalopathy Disease, MELAS Syndrome, Progressive External Ophthalmoplegia, and X-Linked Dominant Scapuloperoneal Myopathy. Dr. Hirano is currently accepting new patients.

Steven Herskovitz, MD, is Director, Neuromuscular Medicine and Director, Electromyography (EMG) Lab at Montefiore. He is also Professor of Neurology at our Albert Einstein College of Medicine. Dr. Herskovitz’s clinical focus is on the evaluation and management of all neuromuscular disorders, with a particular interest in electrodiagnostic and neuromuscular ultrasound assessment. Dr. Herskovitz is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, Multifocal Motor Neuropathy, and Fasciotomy.

Heakyung Kim is a Pediatrics provider practicing medicine in New York, New York. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, and Moebius Syndrome.

Fred Berlin is an Interventional Radiologist practicing medicine in Hackensack, New Jersey. Dr. Berlin is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Ascites, Pleurisy, Pleural Effusion, Liver Embolization, and Gastrostomy.